Lifitegrast in Dry Eye Disease: Clinical Scenarios Requiring Caution

While Lifitegrast plays an important role in managing inflammatory dry eye disease, careful patient selection is essential. This video discusses clinical scenarios where caution is required before initiating Lifitegrast (Lifanta) in patients with dry eye disease.

The discussion focuses on:

• Ocular surface conditions requiring stabilization prior to therapy

• Considerations in patients with epithelial compromise

• Managing tolerability and patient expectations

• Safe integration of Lifitegrast within combination treatment strategies

A practical, experience-driven discussion to support safe and individualized ocular surface management.